Menu

Study: Climate Change Could Threaten Tardigrades

Researchers find that a combination of high temperatures and UV radiation can have negative effects on these hardy creatures.

Dec 20, 2017
Diana Kwon

ISTOCK, ERAXIONTardigrades—microscopic animals that can survive extreme temperatures, years of dehydration, and even a trip to outer space—might not be able to withstand the combined effects of climate change, according to a study published last week (December 14) in the Journal of Experimental Biology.

Scientists at the University of Modena and Reggio Emilia in Italy examined how Acutuncus antarcticus, a tardigrade species native to the Antarctic, would react to climate change–associated stressors such as dehydration, high temperatures, and increased levels of ultraviolet (UV) radiation. While the organisms were able to cope with individual events, a combination of high temperatures and high radiation lowered their chances of survival. 

In addition, the researchers report that tardigrades born from UV-irradiated eggs took longer to reach sexual maturity and produced fewer eggs during their lifetime than those hatched from nonirradiated eggs.

It is not certain that UV radiation at the poles will get worse than it is today, Mark Blaxter, a biologist at the University of Edinburgh who did not take part in the work, tells New Scientist. “Whether this tardigrade is more at risk than, say, apex predators such as penguin, or ecosystem keystones such as krill, is not clear,” he adds.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.